Scinai Immunotherapeutics...

NASDAQ: SCNI · Real-Time Price · USD
1.54
0.01 (0.65%)
At close: Aug 20, 2025, 3:59 PM
1.66
7.73%
After-hours: Aug 20, 2025, 07:59 PM EDT

Scinai Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.87M 14.07M 17.37M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a
Receivables
366K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
140K 250K 241K
Total Current Assets
5.45M 14.37M 17.84M
Property-Plant & Equipment
12.03M 12.7M 14.19M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
12.03M 12.7M 14.19M
Total Assets
17.47M 27.07M 32.04M
Account Payables
535K 716K 999K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
n/a n/a n/a
Total Current Liabilities
1.78M 2.34M 2.44M
Long-Term Debt
19.37M 20.08M 27.16M
Other Long-Term Liabilities
96K 5.33M n/a
Total Long-Term Liabilities
20.26M 26.49M 28.61M
Total Liabilities
22.04M 28.83M 31.05M
Total Debt
20.56M 21.54M 28.98M
Common Stock
n/a n/a n/a
Retained Earnings
-122.33M -115.83M -110.04M
Comprehensive Income
-1.74M -2.01M -2.06M
Shareholders Equity
-4.57M -1.76M 982K
Total Investments
n/a n/a n/a